Mitchell Mcleod Pugh & Williams Inc
Source: SEC Form 13F · as of Mar 2026Mitchell Mcleod Pugh & Williams Inc holds 19 biotech & pharma companies tracked by BioSniper, totaling $33.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$33.0M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 27,868 | $6.8M |
| LLYELI LILLY & Co | 6,224 | $5.7M |
| ABBVAbbVie Inc. | 17,356 | $3.8M |
| MRKMerck & Co., Inc. | 23,390 | $2.8M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 6,457 | $1.7M |
| PMPhilip Morris International Inc | 9,855 | $1.6M |
| PFEPFIZER INC | 43,573 | $1.2M |
| GILDGILEAD SCIENCES, INC. | 8,713 | $1.2M |
| MCKMcKesson Corporation | 1,252 | $1.1M |
| ELVElevance Health Inc. | 3,336 | $977K |
| BMYBRISTOL MYERS SQUIBB CO | 15,053 | $913K |
| NVSNovartis AG | 5,794 | $885K |
| GMOptec International, Inc. | 11,852 | $883K |
| ABTABBOTT LABORATORIES | 6,941 | $713K |
| AMGNAMGEN INC | 1,952 | $687K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,537 | $686K |
| CAHCardinal Health Inc. | 2,460 | $520K |
| DGXQuest Diagnostics Incorporated | 2,494 | $489K |
| GEHCGE HealthCare Technologies Inc. | 3,687 | $262K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.